Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 8, keine Gesamtzahl für „studies“
Suchtreffer
Begriffe & Kennungen
Amlodipine / Valsartan Mylan · 4.5 · Others In clinical interaction studies, amlodipine did not affect the pharmacokinetics of atorvastatin, digoxi
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.8 · The safety of amlodipine/valsartan has been evaluated in five controlled clinical studies with 5,175 patients,
Eintrag öffnenAmyvid · 4.5 · In vitro binding studies have not shown interference of florbetapir (18F) binding to β-amyloid plaques in the
Eintrag öffnenAmyvid · 4.5 · No in vivo interaction studies have been performed.
Eintrag öffnenAmyvid · 4.8 · Adverse reactions observed during clinical studies and post-marketing experience are listed below by frequency
Eintrag öffnenAnomalie der Blutgerinnung
Eintrag öffnenAnoro Ellipta (previously Anoro) · 4.5 · Although no formal in vivo drug interaction studies have been performed, inhaled umeclidinium/vilanterol has b
Eintrag öffnenAnzupgo · 4.5 · No clinical interaction studies have been performed with topically or systemically administered delgocitinib (
Eintrag öffnenAnzupgo · 4.8 · Application site reactions In the pool of three vehicle-controlled clinical studies through 16 weeks, 9 applic
Eintrag öffnenAnzupgo · 4.8 · Table 1 lists the adverse reactions that were observed in clinical studies. The adverse reactions are presente
Eintrag öffnenApidra · 4.5 · Studies on pharmacokinetic interactions have not been performed. Based on empirical knowledge from similar med
Eintrag öffnenApidra · 4.8 · Tabulated list of adverse reactions The following related adverse reactions from clinical studies were listed
Eintrag öffnenApixaban Accord · 4.5 · 44 Effect of apixaban on other medicinal products In vitro apixaban studies showed no inhibitory effect on the
Eintrag öffnenApixaban Accord · 4.5 · Effect of apixaban on other medicinal products In vitro apixaban studies showed no inhibitory effect on the ac
Eintrag öffnenApixaban Accord · 4.5 · In studies conducted in healthy subjects, as described below, apixaban did not meaningfully alter the pharmaco
Eintrag öffnenApixaban Accord · 4.5 · In studies conducted in healthy subjects, as described below, apixaban did not meaningfully alter the pharmaco
Eintrag öffnenApixaban Accord · 4.5 · Interaction studies have not been performed in paediatrics.
Eintrag öffnenApixaban Accord · 4.5 · Interaction studies have not been performed in paediatrics. The above mentioned interaction data was obtained
Eintrag öffnenApixaban Accord · 4.8 · 13 In the VTEt studies, the overall incidence of adverse reactions related to bleeding with apixaban was 15.6%
Eintrag öffnenApixaban Accord · 4.8 · In the NVAF studies, the overall incidence of adverse reactions related to bleeding with apixaban was 24.3% in
Eintrag öffnen